AAAAAA
Results:
1-14
|
Results: 14
Authors:
Oganov, RG
Kiseleva, NG
Citation: Rg. Oganov et Ng. Kiseleva, Sterols and stanols of plant origin: new prospects in prevention of ischemic heart disease, TERAPEVT AR, 73(1), 2001, pp. 33-38
Authors:
Perova, NV
Metelskaya, VA
Oganov, RG
Citation: Nv. Perova et al., Cluster of metabolic syndrome factors: Pathogenetic interrelationships andapproaches to correction, KARDIOLOGIY, 41(3), 2001, pp. 4-9
Authors:
Oganov, RG
Orban, I
Martsevich, SY
Kobalava, ZD
Sidorenko, BA
Almazov, VA
Citation: Rg. Oganov et al., Contenporary use of beta-blockers - Discussion, KARDIOLOGIY, 41(3), 2001, pp. 90-102
Authors:
Metelitsa, VI
Oganov, RG
Citation: Vi. Metelitsa et Rg. Oganov, Myocardial revascularization and drug therapy of ischemic heart disease, TERAPEVT AR, 72(3), 2000, pp. 41-46
Authors:
Oganov, RG
Akhmedzhanov, NM
Citation: Rg. Oganov et Nm. Akhmedzhanov, Atorvastatin - Novel inhibitor of HMG CoA reductase for the treatment of atherosclerosis and dyslipidemia, KARDIOLOGIY, 40(7), 2000, pp. 62-67
Authors:
Oganov, RG
Maslennikova, GY
Citation: Rg. Oganov et Gy. Maslennikova, Cardiovascular diseases in Russian Federation in the second half of the twentieth century: Tendencies, possible causes, perspectives, KARDIOLOGIY, 40(6), 2000, pp. 4-8
Authors:
Akhmedzhanov, NM
Deyanda, DM
Perova, NV
Oganov, RG
Citation: Nm. Akhmedzhanov et al., Lipid lowering activity of cerivastatin in patients with ischemic heart disease, KARDIOLOGIY, 40(12), 2000, pp. 50-55
Authors:
Oganov, RG
Maslennikova, GY
Citation: Rg. Oganov et Gy. Maslennikova, Asthma mortality in Russia between 1980 and 1989, EUR RESP J, 13(2), 1999, pp. 287-289
Authors:
Mamedov, MN
Perova, NV
Metelskaya, VA
Oganov, RG
Citation: Mn. Mamedov et al., Interrelation of abdominal type of obesity and syndrome of insulin resistance in patients with hypertension, KARDIOLOGIY, 39(9), 1999, pp. 18-22
Authors:
Sidorenko, BA
Oganov, RG
Arabidze, GG
Karpov, YA
Doshchitsin, VL
Ivleva, AY
Gratsianskii, NA
Kobalava, ZD
Citation: Ba. Sidorenko et al., The trends in treatment of cardiovascular diseases in the XXI century: Role of angiotensin II blockers receptors - Discussion, KARDIOLOGIY, 39(6), 1999, pp. 86-96
Authors:
Oganov, RG
Belousov, YB
Arabidze, GG
Savenkov, MP
Olbinskaya, LI
Zadionchenko, VS
Citation: Rg. Oganov et al., New drugs in the treatment of cardiovascular deseases and thromboses, KARDIOLOGIY, 39(4), 1999, pp. 86-96
Authors:
Nebieridze, DV
Britov, AN
Aparina, TV
Mamedov, MN
Olferyev, AM
Metelskaya, VA
Oganov, RG
Citation: Dv. Nebieridze et al., Moxonidine - Modern drug of choice in hypertension and metabolic disturbances, KARDIOLOGIY, 39(1), 1999, pp. 43-47
Authors:
Oganov, RG
Perova, NV
Mamedov, MN
Metelskaya, VA
Citation: Rg. Oganov et al., Combination of the metabolic syndrome components in patients with arterialhypertension and their relationship with dyslipidemia, TERAPEVT AR, 70(12), 1998, pp. 19-23
Authors:
Metelitsa, VI
Martsevich, SY
Kozyreva, MP
Oganov, RG
Citation: Vi. Metelitsa et al., Nitrate tolerance: New data on mechanism of development and possibilities of correction, KARDIOLOGIY, 38(12), 1998, pp. 56-63
Risultati:
1-14
|